35090 spending records on file.
18 of 18 publications are not machine-readable
757 of 35090 lack meaningful descriptions
only 755 unique descriptions out of 35090 records
0 of 35090 missing supplier code
0 of 35090 missing supplier name
| Payment date* | Supplier | Description | Kind | Publication | Amount |
|---|---|---|---|---|---|
| 30 Mar 2024 | BAXTER HEALTHCARE LTD | MEDICINES UNCLASSIFIED | Purchase Order | Q1 2024 | €113,504.00 |
| 30 Mar 2024 | DH OPCO UK LTD T/A DEDALUS | COMP S/WARE-MTCE CONT/SUPPORT | Purchase Order | Q1 2024 | €161,220.00 |
| 30 Mar 2024 | BORD GAIS | NATURAL GAS | Purchase Order | Q1 2024 | €114,422.00 |
| 30 Mar 2024 | MDI MEDICAL LIMITED | MEDICAL EQUIP - PURCH >=10K | Purchase Order | Q1 2024 | €101,045.00 |
| 30 Mar 2024 | BARRY'S COACHES LTD | CAR PARK MGT.FEES | Purchase Order | Q1 2024 | €120,420.00 |
| 30 Mar 2024 | BARRY'S COACHES LTD | CAR PARK MGT.FEES | Purchase Order | Q1 2024 | €102,960.00 |
| 30 Mar 2024 | NEIL MARTIN CONSTRUCTION LTD | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €243,008.00 |
| 30 Mar 2024 | UNITED DRUG CO | Other Drugs & Medicines | Purchase Order | Q1 2024 | €105,823.00 |
| 30 Mar 2024 | UNITED DRUG CO | Other Drugs & Medicines | Purchase Order | Q1 2024 | €152,918.00 |
| 30 Mar 2024 | UNITED DRUG CO | Other Drugs & Medicines | Purchase Order | Q1 2024 | €150,980.00 |
| 30 Mar 2024 | SIEMENS HEALTHCARE | Med Eq Pur & Install & Comm Expenditure | Purchase Order | Q1 2024 | €1,197,713.00 |
| 30 Mar 2024 | GLAXOSMITHKLINE (IRELAND) LIMITED | MEDICINES UNCLASSIFIED | Purchase Order | Q1 2024 | €125,430.00 |
| 30 Mar 2024 | SAR SECURITY | SECURITY | Purchase Order | Q1 2024 | €184,314.00 |
| 30 Mar 2024 | PFH TECHNOLOGY | Prof Fees -Extrnl ICT support - Non Clin | Purchase Order | Q1 2024 | €129,347.00 |
| 30 Mar 2024 | LIMETREE NCW PCC LIMITED | Rent/Operating Lease of Buildings | Purchase Order | Q1 2024 | €191,508.00 |
| 30 Mar 2024 | PRIMARY HEALTH PROPERTIES ICAV | Rent/Operating Lease of Buildings | Purchase Order | Q1 2024 | €138,747.00 |
| 30 Mar 2024 | PRIMARY HEALTH PROPERTIES ICAV | Rent/Operating Lease of Buildings | Purchase Order | Q1 2024 | €106,682.00 |
| 30 Mar 2024 | PRIMARY HEALTH PROPERTIES ICAV | Rent/Operating Lease of Buildings | Purchase Order | Q1 2024 | €128,029.00 |
| 30 Mar 2024 | JONES LANG LASALLE LIMITED | Rent/Operating Lease of Buildings | Purchase Order | Q1 2024 | €250,881.00 |
| 30 Mar 2024 | ROYAL COLLEGE OF SURGEONS | Cont Prof Dev (other than CME) Clinical | Purchase Order | Q1 2024 | €202,938.00 |
| 30 Mar 2024 | XIEL LTD | Med Eq Pur & Install & Comm Expenditure | Purchase Order | Q1 2024 | €290,754.00 |
| 30 Mar 2024 | CAREDOC | Med/Dent -Second/Recp Cost-Non DOH | Purchase Order | Q1 2024 | €112,738.00 |
| 30 Mar 2024 | NOONAN SERVICES GROUP | Contract Cleaning - Cleaning & Washing | Purchase Order | Q1 2024 | €269,300.00 |
| 30 Mar 2024 | DELOITTE IRELAND LLP | Prof Fees - ICT rel contractors-Non Clin | Purchase Order | Q1 2024 | €128,070.00 |
| 30 Mar 2024 | EXTRASPACE | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €149,481.00 |
| 30 Mar 2024 | BAXTER HEALTHCARE | Drugs &Med Malignant disease and immunosuppression | Purchase Order | Q1 2024 | €104,659.00 |
| 30 Mar 2024 | BAXTER HEALTHCARE | Drugs &Med Malignant disease and immunosuppression | Purchase Order | Q1 2024 | €148,715.00 |
| 30 Mar 2024 | Skellig Engineering Ltd | Catering Equipment Expenditure | Purchase Order | Q1 2024 | €155,078.00 |
| 30 Mar 2024 | SEAN MURPHY & COMPANY SOLICITO | Legal - 3rd party solicitor fees | Purchase Order | Q1 2024 | €150,000.00 |
| 30 Mar 2024 | ROUGHAN & ODONOVAN CONSULTING | Other professional services Non Clinical | Purchase Order | Q1 2024 | €172,183.00 |
| 30 Mar 2024 | ECONOMIC & SOCIAL RESEARCH INS | Research - Clinical | Purchase Order | Q1 2024 | €140,180.00 |
| 30 Mar 2024 | SCREENLINK HEALTHCARE | Laboratory/Pathology Supplies | Purchase Order | Q1 2024 | €174,987.00 |
| 30 Mar 2024 | ERNST & YOUNG BUSINESS CONSULT | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €112,311.00 |
| 30 Mar 2024 | PRICEWATERHOUSECOOPERS | Diagnostic External Services | Purchase Order | Q1 2024 | €497,035.00 |
| 30 Mar 2024 | CSL Behring GMBH | Other Drugs & Medicines | Purchase Order | Q1 2024 | €117,450.00 |
| 30 Mar 2024 | PFIZER HEALTHCARE IRELAND | J:Antiinfectives -Systemic Use | Purchase Order | Q1 2024 | €825,330.00 |
| 30 Mar 2024 | 3M IRELAND LTD | Goods Received Note pending invoice | Purchase Order | Q1 2024 | €120,158.00 |
| 30 Mar 2024 | UNIPHAR GROUP LTD. | Other Drugs & Medicines | Purchase Order | Q1 2024 | €132,569.00 |
| 30 Mar 2024 | IBM IRELAND LTD | Pur S/ware inc Once-Off Licen Expenditur | Purchase Order | Q1 2024 | €468,899.00 |
| 30 Mar 2024 | VISION CONSULTING LTD | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €393,032.00 |
| 30 Mar 2024 | GRANT THORNTON CORPORATE LTD | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €174,289.00 |
| 30 Mar 2024 | GRANT THORNTON CORPORATE LTD | Non-clinical Management Consultancy | Purchase Order | Q1 2024 | €183,706.00 |
| 30 Mar 2024 | DEASY WALLEY PARTNERSHIP | Other professional services Non Clinical | Purchase Order | Q1 2024 | €116,208.00 |
| 30 Mar 2024 | AFFIDEA DIAGNOSTICS IRELAND LT | Diagnostic External Services | Purchase Order | Q1 2024 | €1,287,260.00 |
| 30 Mar 2024 | CPL HEALTHCARE | RECRUITMENT AGENCY EXPENSES | Purchase Order | Q1 2024 | €162,299.00 |
| 30 Mar 2024 | MAYBIN PROPERTY SUPPORT SERVIC | Cleaning & Washing Services | Purchase Order | Q1 2024 | €606,389.00 |
| 30 Mar 2024 | ERNST & YOUNG BUSINESS CONSULT | Consultancy -Other Client/Patient Serv | Purchase Order | Q1 2024 | €123,597.00 |
| 30 Mar 2024 | ERNST & YOUNG BUSINESS CONSULT | Consultancy -Other Client/Patient Serv | Purchase Order | Q1 2024 | €149,472.00 |
| 30 Mar 2024 | VHI GROUP SERVICES | Legal Fees - Out of Court Settlements | Purchase Order | Q1 2024 | €2,500,000.00 |
| 30 Mar 2024 | VHI GROUP SERVICES | Legal Fees - Out of Court Settlements | Purchase Order | Q1 2024 | €2,500,000.00 |
* Payment date may be the end of the reporting quarter when the entity does not publish an exact date.